Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up. (Q53998750)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up. |
scientific article |
Statements
Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up. (English)
Mortensen L
Charles P
Bekker PJ
Digennaro J
Johnston CC Jr
1 February 1998
83
2
396-402